Inhalation

INH1026

Issue link: https://www.e-digitaleditions.com/i/1546950

Contents of this Issue

Navigation

Page 34 of 43

Inhalation OctOber 2026 33 Bacteriophage for Pulmonary Delivery. Interna- tional Journal of Pharmaceutics 2025, 676, 125602, doi:10.1016/j.ijpharm.2025.125602. 51. Leung, S.S.Y.; Parumasivam, T.; Gao, F.G.; et al. Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections. Pharmaceu- tical Research 2016, 33, 1486-1496, doi:10.1007/ s11095-016-1892-6. 52. Chang, R.Y.K.; Wallin, M.; Kutter, E.; et al. Storage Stability of Inhalable Phage Powders Con- taining Lactose at Ambient Conditions. Interna- tional Journal of Pharmaceutics, 2019, 560, 11-18, doi:10.1016/j.ijpharm.2019.01.050. 53. Chang, R.Y.K.; Kwok, P.C.L.; Khanal, D.; et al. Inhalable Bacteriophage Powders: Glass Transition Temperature and Bioactivity Stabilization. Bioengi- neering & Translational Medicine 2020, 5, e10159, doi:10.1002/btm2.10159. 54. Leung, S.S.Y.; Parumasivam, T.; Nguyen, A.; et al. Effect of Storage Temperature on the Stability of Spray Dried Bacteriophage Powders. European Jour- nal of Pharmaceutics and Biopharmaceutics 2018, 127, 213-222, doi:10.1016/j.ejpb.2018.02.033. 55. Chang, R.Y.K.; Chen, K.; Wang, J.; et al. Proof-of-Principle Study in a Murine Lung Infec- tion Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation. Antimicrobial Agents and Chemotherapy 2017, 62, doi:10.1128/ aac.01714-17. 56. Chang, R.Y.; Wong, J.; Mathai, A.; et al. Produc- tion of Highly Stable Spray Dried Phage Formula- tions for Treatment of Pseudomonas Aeruginosa Lung Infection. European Journal of Pharmaceutics and Biopharmaceutics 2017, 121, 1-13, doi:10.1016/j. ejpb.2017.09.002. 57. Golshahi, L.; Seed, K.; Dennis, J.; et al. Toward Modern Inhalational Bacteriophage erapy: Nebu- lization of Bacteriophages of Burkholderia Cepacia Complex. Journal of Aerosol Medicine and Pulmo- nary Drug Delivery 2008, 21, 351-360, doi:10.1089/ jamp.2008.0701. Shruti S. Sawant, MS, PhD candidate, Research Assistant, Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, Indiana, 47907, US, sawant2@purdue.edu Pharmaceutics 2024, 657, 124146, doi:10.1016/j. ijpharm.2024.124146. 40. Cao, Y.; Wang, Y.; Li, M.; et al. Can Bacterio- phage Be Stabilised by Lipid Encapsulation When Nebulised for Inhalation Delivery against Pseudo- monas Aeruginosa? International Journal of Phar- maceutics 2025, 678, 125670, doi:10.1016/j. ijpharm.2025.125670. 41. Bichet, M.C.; Chin, W.H.; Richards, W.; et al. Bacteriophage Uptake by Mammalian Cell Lay- ers Represents a Potential Sink at May Impact Phage erapy. iScience 2021, 24, doi:10.1016/j. isci.2021.102287. 42. Chang, R.Y.K.; Chow, M.Y.T.; Khanal, D.; et al. Dry Powder Pharmaceutical Biologics for Inhalation erapy. Advanced Drug Delivery Reviews 2021, 172, 64-79, doi:10.1016/j.addr.2021.02.017. 43. Vandenheuvel, D.; Singh, A.; Vandersteegen, et al. Feasibility of Spray Drying Bacteriophages into Respirable Powders to Combat Pulmonary Bacterial Infections. European Journal of Pharmaceutics and Biopharmaceutics 2013, 84, 578-582, doi:10.1016/j. ejpb.2012.12.022. 44. Wang, X.; Xie, Z.; Zhao, J.; et al. Prospects of Inhaled Phage erapy for Combatting Pulmonary Infections. Frontiers in Cellular and Infection Micro- biology 2021, 11, doi:10.3389/fcimb.2021.758392. 45. Matinkhoo, S.; Lynch, K.H.; Dennis, J.J.; et al. Spray-Dried Respirable Powders Containing Bac- teriophages for the Treatment of Pulmonary Infec- tions. Journal of Pharmaceutical Sciences 2011, 100, 5197-5205, doi:10.1002/jps.22715. 46. Li, M.; Ke, W.-R.; Chang, R.Y.K.; et al. Long- Term Storage Stability of Inhalable Phage Powder Formulations: A Four-Year Study. e AAPS Journal 2025, 27, 128, doi:10.1208/s12248-025-01112-y. 47. Merabishvili, M.; Pirnay, J.-P.; Vogele, K.; et al. Production of Phage erapeutics and For- mulations: Innovative Approaches. In Phage erapy: A Practical Approach; Górski, A., Między- brodzki, R., Borysowski, J., Eds.; Springer Inter- national Publishing: Cham, 2019; pp. 3-41 ISBN 978-3-030-26736-0. 48. Kaialy, W.; Nokhodchi, A. Dry Powder Inhal- ers: Physicochemical and Aerosolization Properties of Several Size-Fractions of a Promising Alterative Carrier, Freeze-Dried Mannitol. European Jour- nal of Pharmaceutical Sciences 2015, 68, 56-67, doi:10.1016/j.ejps.2014.12.005. 49. Li, M.; Cao, Y.; Chan, H.-K. Optimizing Per- formance of Inhalable Bacteriophage Powders Using Human Serum Albumin (HSA). Interna- tional Journal of Pharmaceutics 2025, 678, 125709, doi:10.1016/j.ijpharm.2025.125709. 50. Pathak, V.; (Lily) Qu, L.; (Tony) Zhou, Q. Pow- der Aerosol Formulation of Pseudomonas Aeruginosa

Articles in this issue

view archives of Inhalation - INH1026